|
PAN3 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.836800E-03 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.440000E-02 |
| Normal-vs-Stage2 |
9.634100E-02 |
| Normal-vs-Stage3 |
9.495000E-01 |
| Normal-vs-Stage4 |
6.962200E-01 |
| Stage1-vs-Stage2 |
3.696200E-01 |
| Stage1-vs-Stage3 |
1.825610E-01 |
| Stage1-vs-Stage4 |
5.475400E-01 |
| Stage2-vs-Stage3 |
1.070600E-01 |
| Stage2-vs-Stage4 |
1.865840E-01 |
| Stage3-vs-Stage4 |
7.549400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.911940E-02 |
| Normal-vs-AfricanAmerican |
1.514250E-02 |
| Normal-vs-Asian |
4.052800E-01 |
| Caucasian-vs-AfricanAmerican |
3.035000E-01 |
| Caucasian-vs-Asian |
9.803700E-03 |
| AfricanAmerican-vs-Asian |
3.498700E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
7.322800E-03 |
| Normal-vs-Female |
4.237800E-02 |
| Male-vs-Female |
8.985000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.953610E-01 |
| Normal-vs-Extreme_Weight |
1.944240E-01 |
| Normal-vs-Obese |
1.007660E-02 |
| Normal-vs-Extreme_Obese |
5.549200E-01 |
| Normal_Weight-vs-Extreme_Weight |
6.537200E-01 |
| Normal_Weight-vs-Obese |
4.889400E-01 |
| Normal_Weight-vs-Extreme_Obese |
7.010200E-01 |
| Extreme_Weight-vs-Obese |
1.303170E-01 |
| Extreme_Weight-vs-Extreme_Obese |
8.430400E-01 |
| Obese-vs-Extreme_Obese |
3.716000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.250200E-01 |
| Normal-vs-Age(41-60Yrs) |
2.036200E-04 |
| Normal-vs-Age(61-80Yrs) |
1.609820E-01 |
| Normal-vs-Age(81-100Yrs) |
2.512600E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.252410E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.771200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.914300E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.403900E-03 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.580890E-03 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.810000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
2.21739999999304E-05 |
| Normal-VS-Type2 PRCC |
4.940100E-02 |
| Normal-VS-KIRP CIMP |
2.073200E-01 |
| Normal-VS-Unclassified PRCC |
2.871900E-02 |
| Type1 PRCC-VS-Type2 PRCC |
1.69819713846664E-11 |
| Type1 PRCC-VS-KIRP CIMP |
8.03289999999901E-05 |
| Type1 PRCC-VS-Unclassified PRCC |
7.842000E-01 |
| Type2 PRCC-VS-KIRP CIMP |
8.853000E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
1.139300E-03 |
| KIRP CIMP-VS-Unclassified PRCC |
4.437500E-03 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
8.356400E-01 |
| Normal-vs-N1 |
3.366800E-01 |
| Normal-vs-N2 |
2.0618999999944E-05 |
| N0-vs-N1 |
4.587600E-01 |
| N0-vs-N2 |
1.001970E-04 |
| N1-vs-N2 |
5.969400E-04 |
|
|
